• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

男性下尿路症状管理的实用方法。

A practical approach to the management of lower urinary tract symptoms among men.

机构信息

Sydney Urological Associates, Sydney Adventist Hospital, Sydney, NSW.

出版信息

Med J Aust. 2011 Jul 4;195(1):34-9. doi: 10.5694/j.1326-5377.2011.tb03185.x.

DOI:10.5694/j.1326-5377.2011.tb03185.x
PMID:21728939
Abstract

Lower urinary tract symptoms (LUTS) are common among Australian men over the age of 45 years; most men with LUTS will have benign prostatic hyperplasia (BPH), overactive bladder (OAB), or both. The cause of LUTS should be diagnosed by assessing symptom severity and excluding of medical or pharmaceutical causes. All men with LUTS should undergo digital rectal examination; other diagnostic tools include urine and blood testing, voiding charts and imaging. Depending on disease severity, impact on quality of life, patient preference, presence of complications and fitness for surgery, BPH is managed with watchful waiting, pharmacotherapy (α-blockers or 5-α-reductase inhibitors), minimally invasive surgical therapies or surgery. OAB is initially treated with behavioural therapy; if this is ineffective, pharmacotherapy (usually antimuscarinics) can be used. Patients with LUTS with a provisional diagnosis other than BPH or OAB, or with complications or poor response to pharmacotherapy, should be referred to a urologist.

摘要

下尿路症状(LUTS)在 45 岁以上的澳大利亚男性中很常见;大多数有 LUTS 的男性将患有良性前列腺增生(BPH)、膀胱过度活动症(OAB)或两者兼有。通过评估症状严重程度和排除医疗或药物原因来诊断 LUTS 的原因。所有有 LUTS 的男性都应进行直肠指检;其他诊断工具包括尿液和血液检查、排尿图表和影像学检查。根据疾病严重程度、对生活质量的影响、患者偏好、并发症的存在以及手术适应性,BPH 通过观察等待、药物治疗(α 受体阻滞剂或 5-α 还原酶抑制剂)、微创外科治疗或手术进行管理。OAB 最初采用行为疗法治疗;如果无效,可以使用药物治疗(通常是抗毒蕈碱药物)。对于暂时诊断为 BPH 或 OAB 以外的 LUTS 患者、或有并发症或药物治疗反应不佳的患者,应转介给泌尿科医生。

相似文献

1
A practical approach to the management of lower urinary tract symptoms among men.男性下尿路症状管理的实用方法。
Med J Aust. 2011 Jul 4;195(1):34-9. doi: 10.5694/j.1326-5377.2011.tb03185.x.
2
[Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].[良性前列腺增生相关下尿路症状的初始评估、随访及治疗:法国泌尿外科学会下尿路症状委员会指南]
Prog Urol. 2012 Dec;22(16):977-88. doi: 10.1016/j.purol.2012.10.001. Epub 2012 Nov 6.
3
Benign prostatic hyperplasia and lower urinary tract symptoms: evidence and approaches for best case management.良性前列腺增生与下尿路症状:最佳病例管理的证据与方法
Can J Urol. 2011 Apr;18 Suppl:14-9.
4
Comparative Effectiveness of Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis.新型药物治疗良性前列腺增生所致下尿路症状的比较有效性:一项系统评价和荟萃分析。
Eur Urol. 2017 Apr;71(4):570-581. doi: 10.1016/j.eururo.2016.09.032. Epub 2016 Oct 4.
5
Estimating the quality-of-life impact and cost-effectiveness of alpha-blocker and anti-muscarinic combination treatment in men with lower urinary tract symptoms related to benign prostatic hyperplasia and overactive bladder.评估 α 受体阻滞剂和抗毒蕈碱药物联合治疗与良性前列腺增生和膀胱过度活动症相关的下尿路症状男性患者的生活质量影响和成本效益。
J Med Econ. 2012;15(3):586-600. doi: 10.3111/13696998.2012.666511. Epub 2012 Feb 24.
6
Benign Prostatic Hyperplasia.良性前列腺增生
Prim Care. 2019 Jun;46(2):223-232. doi: 10.1016/j.pop.2019.02.003. Epub 2019 Apr 1.
7
Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study.药物治疗对良性前列腺增生相关下尿路症状患者的药物依从性和临床结局:基于人群的队列研究。
Eur Urol. 2015 Sep;68(3):418-25. doi: 10.1016/j.eururo.2014.11.006. Epub 2014 Nov 20.
8
Medical therapy for benign prostatic hyperplasia: a review.良性前列腺增生的药物治疗:综述
Can J Urol. 2015 Oct;22 Suppl 1:7-17.
9
Prevalence of lower urinary tract symptoms and self-reported diagnosed 'benign prostatic hyperplasia', and their effect on quality of life in a community-based survey of men in the UK.英国一项基于社区的男性调查中,下尿路症状和自我报告诊断的“良性前列腺增生”的患病率及其对生活质量的影响。
BJU Int. 1999 Mar;83(4):410-5. doi: 10.1046/j.1464-410x.1999.00966.x.
10
EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction.EAU 指南:非神经原性男性下尿路症状(包括良性前列腺梗阻)的治疗和随访。
Eur Urol. 2013 Jul;64(1):118-40. doi: 10.1016/j.eururo.2013.03.004. Epub 2013 Mar 13.

引用本文的文献

1
Undertreatment of overactive bladder among men with lower urinary tract symptoms in the United States: A retrospective observational study.美国下尿路症状男性中过度膀胱活动症的治疗不足:一项回顾性观察研究。
Neurourol Urodyn. 2020 Jun;39(5):1378-1386. doi: 10.1002/nau.24348. Epub 2020 May 8.
2
Efficacy and tolerability of lipid extract (D-004) and terazosin in men with symptomatic benign prostatic hyperplasia: a 6-month study.脂质提取物(D - 004)与特拉唑嗪治疗有症状的良性前列腺增生男性的疗效和耐受性:一项为期6个月的研究。
Ther Adv Urol. 2019 Jun 11;11:1756287219854923. doi: 10.1177/1756287219854923. eCollection 2019 Jan-Dec.
3
Drugs for benign prostatic hypertrophy.
治疗良性前列腺增生的药物。
Aust Prescr. 2018 Oct;41(5):150-153. doi: 10.18773/austprescr.2018.045. Epub 2018 Oct 1.
4
Factors related to receipt of non-cancer-related transurethral prostatectomy: findings from a large prospective study of 106 769 middle-aged and older Australian men.与非癌症相关的经尿道前列腺切除术相关的因素:来自对 106769 名澳大利亚中老年男性进行的一项大型前瞻性研究的结果。
BMJ Open. 2017 Feb 8;7(2):e013737. doi: 10.1136/bmjopen-2016-013737.
5
Evaluation and management of male lower urinary tract symptoms: treatment patterns and guidelines in a correlation study among Polish urology consultants.男性下尿路症状的评估与管理:波兰泌尿外科顾问相关性研究中的治疗模式与指南
Arch Med Sci. 2015 Dec 10;11(6):1340-51. doi: 10.5114/aoms.2015.56358. Epub 2015 Dec 11.
6
Early experience photoselective vaporisation of the prostate using the 180W lithium triborate and comparison with the 120W lithium triborate laser.早期使用 180W 三硼酸锂的前列腺选择性光汽化术的经验,并与 120W 三硼酸锂激光进行比较。
Prostate Int. 2013;1(1):42-5. doi: 10.12954/PI.12006. Epub 2013 Feb 4.